Aethlon Medical Valuation
| AEMD Stock | USD 1.24 0.06 5.08% |
Today, the firm appears to be overvalued. Aethlon Medical shows a prevailing Real Value of $1.19 per share. The current price of the firm is $1.24. Our model approximates the value of Aethlon Medical from analyzing the firm fundamentals such as Current Valuation of (1.65 M), shares owned by insiders of 0.94 %, and Return On Equity of -2.46 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Aethlon Medical's price fluctuation is abnormally volatile at this time. Calculation of the real value of Aethlon Medical is based on 3 months time horizon. Increasing Aethlon Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aethlon stock is determined by what a typical buyer is willing to pay for full or partial control of Aethlon Medical. Since Aethlon Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aethlon Stock. However, Aethlon Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.24 | Real 1.19 | Hype 1.24 | Naive 1.4 |
The real value of Aethlon Stock, also known as its intrinsic value, is the underlying worth of Aethlon Medical Company, which is reflected in its stock price. It is based on Aethlon Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aethlon Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aethlon Medical helps investors to forecast how Aethlon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aethlon Medical more accurately as focusing exclusively on Aethlon Medical's fundamentals will not take into account other important factors: Aethlon Medical Total Value Analysis
Aethlon Medical is presently expected to have valuation of (1.65 M) with market capitalization of 3.21 M, debt of 649.75 M, and cash on hands of 14.92 M. The negative valuation of Aethlon Medical may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Aethlon Medical fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.65 M) | 3.21 M | 649.75 M | 14.92 M |
Aethlon Medical Asset Utilization
One of the ways to look at asset utilization of Aethlon is to check how much profit was generated for every dollar of assets it reports. Aethlon Medical shows a negative utilization of assets of -0.75 percent, losing $0.007482 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Aethlon Medical shows how discouraging it operates for each dollar spent on its assets.Aethlon Medical Ownership Allocation
Almost 77.92 percent of Aethlon Medical outstanding shares are held by general public with 0.94 (percent) owned by insiders and only 21.14 % by other corporate entities.Aethlon Medical Profitability Analysis
Net Loss for the year was (13.39 B) with profit before overhead, payroll, taxes, and interest of 574.25 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aethlon Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aethlon Medical and how it compares across the competition.
About Aethlon Medical Valuation
The stock valuation mechanism determines Aethlon Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Aethlon Medical. We calculate exposure to Aethlon Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aethlon Medical's related companies.Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Aethlon Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aethlon Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.6 M | |
| Forward Price Earnings | 0.2102 |
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |